Emilio Ribas Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2008
NCT00427414
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Instituto De Infectologia Emilio Ribas Hospital

Active Ingredients

Drugs in Phase 1 Trials (1)

daunoxome (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sarcoma (Phase 1)

Sarcoma, Kaposi (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1